Researchers at the Case Western Reserve University School of Medicine have identified a new target in the development of Alzheimer's disease (AD) that could lead to therapies focused on treating the neurodegenerative condition early in its progression. The discovery helps bolster a promising approach to AD research: finding and manipulating processes earlier in the disease's